What is the level of liabilities of Sino Biopharmaceutical this year?
Sino Biopharmaceutical has a debt balance of 33.13 B CNY this year.
In 2024, Sino Biopharmaceutical's total liabilities amounted to 33.13 B CNY, a -3.46% difference from the 34.32 B CNY total liabilities in the previous year.
Sino Biopharmaceutical's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Sino Biopharmaceutical's financial stability, operational efficiency, and long-term viability.
By comparing Sino Biopharmaceutical's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Sino Biopharmaceutical's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Shifts in Sino Biopharmaceutical’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Sino Biopharmaceutical has a debt balance of 33.13 B CNY this year.
The liabilities of Sino Biopharmaceutical have increased by -3.46% dropped compared to the previous year.
High liabilities can pose a risk for investors of Sino Biopharmaceutical, as they can weaken the company's financial position and impair its ability to meet its obligations.
Low liabilities mean that Sino Biopharmaceutical has a strong financial position and is able to meet its obligations without overburdening its finances.
An increase in liabilities of Sino Biopharmaceutical can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
A decrease in the liabilities of Sino Biopharmaceutical can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
Some factors that can influence the liabilities of Sino Biopharmaceutical include investments, acquisitions, operating costs, and sales development.
The liabilities of Sino Biopharmaceutical are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
To change its liabilities, Sino Biopharmaceutical can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
Over the past 12 months, Sino Biopharmaceutical paid a dividend of 0.08 CNY . This corresponds to a dividend yield of about 2.73 %. For the coming 12 months, Sino Biopharmaceutical is expected to pay a dividend of 0.08 CNY.
The current dividend yield of Sino Biopharmaceutical is 2.73 %.
Sino Biopharmaceutical pays a quarterly dividend. This is distributed in the months of November, July, October, October.
Sino Biopharmaceutical paid dividends every year for the past 26 years.
For the upcoming 12 months, dividends amounting to 0.08 CNY are expected. This corresponds to a dividend yield of 2.84 %.
Sino Biopharmaceutical is assigned to the 'Health' sector.
To receive the latest dividend of Sino Biopharmaceutical from 10/4/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 9/12/2024.
The last dividend was paid out on 10/4/2024.
In the year 2023, Sino Biopharmaceutical distributed 0.1 CNY as dividends.
The dividends of Sino Biopharmaceutical are distributed in CNY.
Our stock analysis for Sino Biopharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sino Biopharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.